๐ฐ Thomas Ybert News
Page 2 - Thomas Ybert News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thomas Ybert. Real-time updates on events, politics, business and more.
April 6, 2022
The French synthetic biology company said that the agreements expand the global footprint for its Syntax benchtop enzymatic DNA synthesis platform.
April 5, 2022
Company expands worldwide footprint to China, Hong Kong, India, Singapore, South Korea and Taiwan for sales, distribution, and support of enzymatic synthesis products DNA Script, a world leader in
March 11, 2022
DNA Script Named to Fast Companyโs Annual List of the Worldโs 50 Most Innovative Companies for 2022 - read this article along with other careers information, tips and advice on BioSpace
February 14, 2022
The short oligo ligation assembly (SOLA) enzymatic DNA synthesis method uses a library of DNA building blocks to make oligos that are then assembled into genes.
February 2, 2022
Multi-year, multi-million dollar collaboration will develop new tools to rapidly accelerate the development of RNA-based products, catalyzing a new era in healthcare DNA Script, a leader in Enzymatic
January 7, 2022
Check out new developments from DNA Script, DermBiont, Healthmine, and more.
January 5, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
January 5, 2022
Company to Present Monday, January 10, 2022, at 2 p.m. EST DNA Script, a leader in Enzymatic DNA Synthesis (EDS) for on-demand DNA printing, today announced that its CEO and co-founder Thomas Ybert
January 4, 2022
Accounts and funds advised by T. Rowe Price Associates, Inc. andBaillie Gifford join syndicate of investors Funding to accelerate commercial launch of revolutionary enzymatic DNA printing technology DNA
October 26, 2021
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!